Directa Plus Share Discussion Threads

[pawdaw] 02/12/2022 08:57

Poorly structured statement with the negatives and difficulties up front and the positives buried beneath.

[toffeeman] 02/12/2022 08:49

Bad Gateway called it right

[farrugia] 02/12/2022 08:46

Do Directa Plus products actually use graphene as a material to enhance the products?

[scepticalinvestor] 02/12/2022 08:18

Timberrrrrrrr

[bad gateway] 04/11/2022 14:17

Lost the declining 50dsma today. Getting ever closer to want to close the gap at 76p.

[hew] 28/10/2022 07:51

In the graphene application world I see any RNS about a commercial deal as significant, but DCTA's today as particularly so. A Latin American base but worldwide distribution for a notable application field.

I see that their UK distribution base is in Hereford.

[beergut] 28/10/2022 06:11

More great news and $1,000,000 minimum over 4 hears. Let's hope this bullet proofs the share price

[beergut] 24/10/2022 07:50

€1M = €4,000 per Km

That doesn't seem too bad for providing a small part of the materials required for the road.

How many thousands of Km are replaced each year across Europe?

[bad gateway] 24/10/2022 07:28

re the new road contract. Cenkos have it as being a 125km section the 250km refers to both sides of the road being done apparently and the contract is worth €1M over the 18 months of said contract to DCTA.

[bbluesky] 21/10/2022 08:14

This is an astounding RNS, not just for the company but the World.

This sets a new standard in roadbuilding, the figures are extraordinary and I genuinely we believe we are witnessing the start of a new era, 240km now....

[bad gateway] 21/10/2022 07:50

lol but agreed. Still sounds a decent start for gipave though about time they started getting a few contracts under their belt.

[beergut] 21/10/2022 06:44

Great news this morning, but let's hope they earn more than £100,000 on this contract and get the needle moving on earnings

[bbluesky] 29/9/2022 14:28

Cenkos maintain their 280p target and Singer's have a Buy note out.

[bbluesky] 23/9/2022 09:44

Why repeat what you posted on 1 September? I wonder?

[rock star] 23/9/2022 07:20

Singers big downgrade to 140p was based on the Italian energy price spike.

[smokeyjohnson] 20/9/2022 08:53

Hopefully we'll hear about this soon (from June AGM Statement)

"Directa Plus remains optimistic on its ability to secure a very material contract for which it has tendered via the Company's subsidiary, Setcar, for Environmental Remediation services. The Company now expects a decision on the tender in early H2 2022. The contract is significantly larger than anything secured to date and, if awarded, it is expected to commence by year end."

And from Sept 1st RNS

"Directa Plus still awaits the final decision on the award of a significant tender in Romania for its Environmental Remediation services, and the Directors continue to believe that the Company is well positioned to win the tender."

[bbluesky] 01/9/2022 09:56

Cenkos seem more likeminded "Solid !st half 2022 1st half update". Singers downgrade seemed from 225p to 140p rather at odds with the news.

Cenkos reiterate "Buy recommendation and 280p valuation which we believe leaves significant room for upgrades."

[bad gateway] 01/9/2022 07:23

Agreed, bit disappointed Setcar isn't winning contracts at the rate they indicated in the podcast last Oct but still see good progress and will continue to hold.

[melody9999] 01/9/2022 07:19

thought the TU was very positive. No reason not to keep holding and just wait for the markets to recognise the undervaluation here.

[rock star] 01/9/2022 07:15

Downgraded by Singers 225p to 140p?

[terry topper] 12/8/2022 11:22

I was wondering what had happened with the Gipave trials and found this:


It all sounds broadly positive but decent revenues are probably still some way off as there are going to be further trials later this year before Kent County Council decides whether to use Gipave to "resurface some of its busiest roads".

Of course, other councils and road resurfacing companies will be watching with interest and would presumably be happy to rely on the trial results from Kent so that Gipave revenues could ramp up very quickly in 2-3 years.